Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients.
暂无分享,去创建一个
S. Lakhani | P. Selby | C. Viner | T. Mcelwain | G. Zulian | J. Maitland | G. Forgeson
[1] J. Chang,et al. VAD chemotherapy—toxicity and efficacy—in patients with multiple myeloma and other lymphoid malignancies , 1987, Hematological oncology.
[2] M. Slevin,et al. Multiple myeloma treated with high dose intravenous melphalan , 1987, British journal of haematology.
[3] B. Barlogie,et al. High-dose glucocorticoid treatment of resistant myeloma. , 1986, Annals of internal medicine.
[4] B. Barlogie,et al. Effective treatment of advanced multiple myeloma refractory to alkylating agents. , 1984, The New England journal of medicine.
[5] G. Bodey,et al. Prednisone pulse therapy for refractory myeloma. , 1983, Blood.
[6] M. Palmer,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.
[7] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.